Symbols / STVN $15.56 +1.37% Stevanato Group S.p.A.

Healthcare • Medical Instruments & Supplies • Italy • NYQ
STVN Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Fundamentals
Scroll to Statements
Market Cap 4.25B Enterprise Value 4.59B Income 139.84M Sales 1.19B Book/sh 6.42 Cash/sh 0.48
Dividend Yield 41.00% Payout 10.59% Employees 6010 IPO — P/E 25.93 Forward P/E 18.20
PEG 3.57 P/S 3.58 P/B 2.42 P/C — EV/EBITDA 16.17 EV/Sales 3.87
Quick Ratio 1.25 Current Ratio 1.76 Debt/Eq 31.60 LT Debt/Eq — EPS (ttm) 0.60 EPS next Y 0.85
EPS Growth 0.30% Revenue Growth 4.80% Earnings 2026-05-07 ROA 5.23% ROE 9.67% ROIC —
Gross Margin 29.18% Oper. Margin 20.88% Profit Margin 11.79% Shs Outstand 49.71M Shs Float 48.95M Short Float 2.37%
Short Ratio 1.98 Short Interest — 52W High 28.00 52W Low 12.89 Beta 0.62 Avg Volume 716.60K
Volume 442.18K Target Price $24.72 Recom Buy Prev Close $15.35 Price $15.56 Change 1.37%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$24.72
Mean price target
2. Current target
$15.56
Latest analyst target
3. DCF / Fair value
$-16.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$15.56
Low
$17.50
High
$32.00
Mean
$24.72

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-06 main Morgan Stanley Equal-Weight → Equal-Weight $19
2026-03-05 main Citigroup Buy → Buy $26
2026-03-05 main Keybanc Overweight → Overweight $32
2025-12-02 main Morgan Stanley Equal-Weight → Equal-Weight $24
2025-11-11 main Morgan Stanley Equal-Weight → Equal-Weight $26
2025-03-07 main UBS Neutral → Neutral $24
2024-12-13 main B of A Securities Buy → Buy $26
2024-12-13 init Wolfe Research — → Outperform $28
2024-08-07 main Citigroup Buy → Buy $28
2024-07-15 main Morgan Stanley Equal-Weight → Equal-Weight $22
2024-04-22 main Morgan Stanley Equal-Weight → Equal-Weight $30
2024-03-25 reit Stephens & Co. Overweight → Overweight $38
2023-11-01 main Morgan Stanley Equal-Weight → Equal-Weight $30
2023-11-01 down Jefferies Buy → Hold $29
2023-09-26 init Stephens & Co. — → Overweight $33
2023-09-19 init CJS Securities — → Market Outperform $36
2023-08-30 main Keybanc Overweight → Overweight $37
2023-08-24 down Morgan Stanley Overweight → Equal-Weight $34
2023-07-31 main Morgan Stanley Overweight → Overweight $34
2023-07-31 main Wells Fargo Overweight → Overweight $35
News
RSS: Latest STVN news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,186.28
+7.45%
1,104.04
+1.72%
1,085.35
+10.34%
983.68
Operating Revenue
1,186.28
+7.45%
1,104.04
+1.72%
1,085.35
+10.34%
983.68
Cost Of Revenue
842.41
+5.08%
801.72
+7.55%
745.46
+12.29%
663.88
Reconciled Cost Of Revenue
762.66
+4.40%
730.53
+8.07%
676.01
+1.83%
663.88
Gross Profit
343.88
+13.75%
302.32
-11.05%
339.89
+6.28%
319.80
Operating Expense
145.07
+2.76%
141.18
+1.44%
139.17
+9.27%
127.37
Research And Development
25.44
-19.68%
31.67
-11.22%
35.67
+3.74%
34.39
Selling General And Administration
119.06
+9.10%
109.13
+4.04%
104.90
-6.20%
111.83
Selling And Marketing Expense
27.66
+14.02%
24.26
-0.07%
24.28
-6.93%
26.09
General And Administrative Expense
91.40
+7.69%
84.87
+5.27%
80.62
-5.98%
85.75
Other Gand A
91.40
+7.69%
84.87
+5.27%
80.62
-5.98%
85.75
Other Operating Expenses
-8.24
+9.32%
-9.09
+12.78%
-10.42
+44.71%
-18.85
Total Expenses
987.48
+4.73%
942.89
+6.59%
884.63
+11.80%
791.25
Operating Income
198.80
+23.37%
161.14
-19.72%
200.72
+4.31%
192.43
Total Operating Income As Reported
198.80
+23.37%
161.14
-19.72%
200.72
+4.31%
192.43
EBITDA
284.15
+14.67%
247.80
-9.01%
272.35
+6.22%
256.40
Normalized EBITDA
288.08
+18.64%
242.82
-13.21%
279.78
+8.53%
257.79
Reconciled Depreciation
88.57
+9.81%
80.65
+2.77%
78.48
+21.07%
64.82
EBIT
195.59
+17.01%
167.15
-13.78%
193.87
+1.20%
191.58
Total Unusual Items
-3.93
-178.85%
4.98
+167.03%
-7.44
-436.51%
-1.39
Total Unusual Items Excluding Goodwill
-3.93
-178.85%
4.98
+167.03%
-7.44
-436.51%
-1.39
Special Income Charges
—
—
0.00
0.00
Net Income
139.84
+18.73%
117.78
-19.13%
145.63
+1.95%
142.85
Pretax Income
189.11
+17.98%
160.29
-15.44%
189.55
+1.02%
187.64
Net Non Operating Interest Income Expense
-5.76
+1.25%
-5.84
-56.47%
-3.73
-9.61%
-3.40
Interest Expense Non Operating
6.48
-5.55%
6.86
+59.07%
4.32
+9.63%
3.94
Net Interest Income
-5.76
+1.25%
-5.84
-56.47%
-3.73
-9.61%
-3.40
Interest Expense
6.48
-5.55%
6.86
+59.07%
4.32
+9.63%
3.94
Interest Income Non Operating
1.03
-40.22%
1.72
+117.55%
0.79
+22.22%
0.65
Interest Income
1.03
-40.22%
1.72
+117.55%
0.79
+22.22%
0.65
Other Income Expense
-3.93
-178.85%
4.98
+167.03%
-7.44
-436.51%
-1.39
Gain On Sale Of Security
-3.93
-178.85%
4.98
+167.03%
-7.44
-436.51%
-1.39
Gain On Sale Of Business
—
—
0.00
0.00
Tax Provision
49.27
+15.88%
42.52
-3.06%
43.86
-1.71%
44.62
Tax Rate For Calcs
0.00
-1.51%
0.00
+14.72%
0.00
-2.94%
0.00
Tax Effect Of Unusual Items
-1.03
-177.66%
1.32
+176.89%
-1.72
-420.73%
-0.33
Net Income Including Noncontrolling Interests
139.83
+18.74%
117.77
-19.17%
145.69
+1.87%
143.02
Net Income From Continuing Operation Net Minority Interest
139.84
+18.73%
117.78
-19.13%
145.63
+1.95%
142.85
Net Income From Continuing And Discontinued Operation
139.84
+18.73%
117.78
-19.13%
145.63
+1.95%
142.85
Net Income Continuous Operations
139.83
+18.74%
117.77
-19.17%
145.69
+1.87%
143.02
Minority Interests
0.01
-33.33%
0.01
+120.34%
-0.06
+64.67%
-0.17
Normalized Income
142.74
+25.09%
114.11
-24.60%
151.35
+5.17%
143.91
Net Income Common Stockholders
139.84
+18.73%
117.78
-19.13%
145.63
+1.95%
142.85
Diluted EPS
0.51
+18.60%
0.43
-21.82%
0.55
+1.85%
0.54
Basic EPS
0.51
+18.60%
0.43
-21.82%
0.55
+1.85%
0.54
Basic Average Shares
272.95
+0.68%
271.10
+2.32%
264.95
+0.09%
264.70
Diluted Average Shares
272.96
+0.65%
271.20
+2.35%
264.98
+0.10%
264.70
Diluted NI Availto Com Stockholders
139.84
+18.73%
117.78
-19.13%
145.63
+1.95%
142.85
Depreciation Amortization Depletion Income Statement
8.82
-6.83%
9.47
+4.91%
9.03
—
Depreciation And Amortization In Income Statement
8.82
-6.83%
9.47
+4.91%
9.03
—
Earnings From Equity Interest
—
—
0.00
0.00
Total Other Finance Cost
0.31
-55.24%
0.70
+235.10%
0.21
+79.31%
0.12
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,543.97
+9.24%
2,328.82
+12.42%
2,071.58
+24.82%
1,659.70
Current Assets
943.35
+7.18%
880.12
+2.12%
861.89
+1.91%
845.77
Cash Cash Equivalents And Short Term Investments
130.60
+32.90%
98.27
+39.69%
70.35
-72.59%
256.65
Cash And Cash Equivalents
130.60
+32.90%
98.27
+41.19%
69.60
-69.57%
228.74
Other Short Term Investments
—
0.00
-100.00%
0.75
-97.32%
27.91
Receivables
539.47
+1.81%
529.87
+1.41%
522.48
+41.41%
369.48
Accounts Receivable
302.69
+2.28%
295.95
-1.93%
301.77
+41.85%
212.73
Gross Accounts Receivable
309.77
+2.35%
302.65
-1.87%
308.43
+41.03%
218.69
Allowance For Doubtful Accounts Receivable
-7.08
-5.67%
-6.70
-0.72%
-6.66
-11.66%
-5.96
Other Receivables
203.99
+8.45%
188.09
+0.81%
186.57
+62.33%
114.94
Taxes Receivable
32.55
-28.01%
45.21
+32.43%
34.14
-18.34%
41.81
Accrued Interest Receivable
0.25
-59.87%
0.62
0.00
—
Inventory
268.25
+9.39%
245.22
-3.96%
255.32
+19.73%
213.25
Raw Materials
138.57
+19.86%
115.60
-5.31%
122.08
+14.89%
106.26
Work In Process
50.97
-4.66%
53.46
+39.42%
38.35
+26.99%
30.20
Finished Goods
99.67
+3.64%
96.18
-14.91%
113.03
+21.55%
92.99
Prepaid Assets
3.09
-47.03%
5.83
-42.29%
10.11
+1337.70%
0.70
Assets Held For Sale Current
0.00
-100.00%
0.22
0.00
—
Hedging Assets Current
1.94
+173.00%
0.71
-80.43%
3.63
-36.20%
5.69
Total Non Current Assets
1,600.62
+10.49%
1,448.70
+19.76%
1,209.68
+48.62%
813.92
Net PPE
1,403.92
+11.06%
1,264.14
+20.77%
1,046.74
+58.43%
660.69
Gross PPE
2,031.01
+11.06%
1,828.68
+17.59%
1,555.12
+41.79%
1,096.77
Accumulated Depreciation
-627.09
-11.08%
-564.54
-11.05%
-508.38
-16.58%
-436.07
Properties
0.00
0.00
0.00
0.00
Land And Improvements
497.22
+27.30%
390.57
+91.82%
203.62
+22.35%
166.42
Buildings And Improvements
25.83
-0.52%
25.96
+12.79%
23.02
+12.19%
20.52
Machinery Furniture Equipment
890.99
+17.80%
756.35
+20.88%
625.68
+17.48%
532.58
Construction In Progress
494.63
-9.57%
546.99
-10.72%
612.69
+105.24%
298.53
Other Properties
122.35
+12.45%
108.81
+20.74%
90.12
+14.48%
78.72
Goodwill And Other Intangible Assets
86.85
+3.92%
83.57
+3.22%
80.97
+1.97%
79.40
Goodwill
49.98
+0.00%
49.98
+0.00%
49.98
+5.80%
47.24
Other Intangible Assets
36.87
+9.75%
33.59
+8.41%
30.98
-3.65%
32.16
Investments And Advances
5.64
+0.00%
5.64
+9.51%
5.15
+182.09%
1.83
Long Term Equity Investment
—
—
—
—
Non Current Accounts Receivable
—
—
—
—
Non Current Deferred Assets
103.87
+8.94%
95.34
+25.04%
76.25
+10.17%
69.21
Non Current Deferred Taxes Assets
103.87
+8.94%
95.34
+25.04%
76.25
+10.17%
69.21
Total Liabilities Net Minority Interest
1,057.45
+14.39%
924.43
-1.54%
938.93
+41.45%
663.79
Current Liabilities
535.88
+12.23%
477.47
-16.87%
574.39
+24.19%
462.50
Payables And Accrued Expenses
343.53
+12.47%
305.43
-15.86%
363.00
+10.03%
329.91
Payables
343.53
+12.47%
305.43
-15.86%
363.00
+10.03%
329.91
Accounts Payable
263.31
+13.98%
231.02
-16.84%
277.81
+16.15%
239.18
Other Payable
50.53
+19.33%
42.34
-3.89%
44.06
-1.65%
44.80
Current Accrued Expenses
—
—
—
12.47
Employee Benefits
6.78
-5.29%
7.16
-3.37%
7.41
-10.85%
8.31
Total Tax Payable
29.69
-7.39%
32.06
-22.04%
41.13
-10.47%
45.94
Current Debt And Capital Lease Obligation
121.75
+8.77%
111.93
-20.86%
141.44
+102.17%
69.96
Current Debt
117.36
+9.85%
106.84
-21.21%
135.60
+109.79%
64.63
Other Current Borrowings
87.36
+53.78%
56.81
+10.12%
51.59
+0.40%
51.39
Current Capital Lease Obligation
4.38
-13.94%
5.09
-12.82%
5.84
+9.69%
5.33
Current Deferred Liabilities
56.97
+27.54%
44.67
-24.03%
58.80
+9.12%
53.89
Current Deferred Revenue
56.97
+27.54%
44.67
-24.03%
58.80
+9.12%
53.89
Other Current Liabilities
9.24
-18.28%
11.31
+12.10%
10.09
+15.32%
8.75
Total Non Current Liabilities Net Minority Interest
521.58
+16.69%
446.96
+22.61%
364.54
+81.11%
201.29
Long Term Debt And Capital Lease Obligation
347.16
+9.50%
317.04
+24.25%
255.15
+71.93%
148.41
Long Term Debt
337.78
+10.67%
305.23
+26.10%
242.05
+80.97%
133.75
Long Term Capital Lease Obligation
9.38
-20.59%
11.81
-9.88%
13.10
-10.60%
14.66
Long Term Provisions
3.16
+13.21%
2.79
-29.74%
3.98
-28.40%
5.55
Non Current Deferred Liabilities
112.11
+98.05%
56.61
+15.42%
49.04
+134.07%
20.95
Non Current Deferred Revenue
98.85
+124.42%
44.05
+11.74%
39.42
0.00
Non Current Deferred Taxes Liabilities
13.26
+5.57%
12.56
+30.51%
9.62
-54.07%
20.95
Other Non Current Liabilities
52.16
-16.84%
62.72
+29.39%
48.47
+168.41%
18.06
Stockholders Equity
1,486.48
+5.85%
1,404.34
+24.00%
1,132.53
+13.69%
996.13
Common Stock Equity
1,486.48
+5.85%
1,404.34
+24.00%
1,132.53
+13.69%
996.13
Capital Stock
22.23
+0.00%
22.23
+2.46%
21.70
+0.00%
21.70
Common Stock
22.23
+0.00%
22.23
+2.46%
21.70
+0.00%
21.70
Share Issued
302.84
+0.00%
302.84
+14.08%
265.47
-10.18%
295.54
Ordinary Shares Number
273.00
+0.04%
272.90
+2.80%
265.47
+0.29%
264.70
Treasury Shares Number
29.84
-0.35%
29.94
-0.43%
30.07
-2.49%
30.84
Additional Paid In Capital
559.57
+0.00%
559.57
+43.73%
389.31
+0.00%
389.31
Retained Earnings
990.43
+14.71%
863.44
+13.93%
757.86
+21.58%
623.35
Gains Losses Not Affecting Retained Earnings
-58.66
-326.63%
-13.75
-51.02%
-9.11
+13.23%
-10.49
Treasury Stock
27.08
-0.25%
27.15
-0.31%
27.23
-1.83%
27.74
Minority Interest
0.04
-17.39%
0.05
-60.00%
0.12
+152.27%
-0.22
Other Equity Adjustments
-0.20
+83.28%
-1.17
-162.64%
1.87
-63.44%
5.12
Total Equity Gross Minority Interest
1,486.52
+5.85%
1,404.38
+23.99%
1,132.65
+13.73%
995.91
Total Capitalization
1,824.27
+6.71%
1,709.57
+24.37%
1,374.58
+21.66%
1,129.88
Working Capital
407.47
+1.20%
402.65
+40.05%
287.50
-24.99%
383.27
Invested Capital
1,941.63
+6.89%
1,816.41
+20.28%
1,510.17
+26.43%
1,194.51
Total Debt
468.90
+9.31%
428.97
+8.16%
396.59
+81.62%
218.37
Net Debt
324.54
+3.42%
313.80
+1.87%
308.04
—
Capital Lease Obligations
13.76
-18.59%
16.90
-10.79%
18.95
-5.19%
19.98
Net Tangible Assets
1,399.63
+5.97%
1,320.77
+25.60%
1,051.56
+14.71%
916.73
Tangible Book Value
1,399.63
+5.97%
1,320.77
+25.60%
1,051.56
+14.71%
916.73
Available For Sale Securities
1.26
-16.03%
1.50
+16.24%
1.29
+23.85%
1.04
Current Provisions
4.39
+6.16%
4.14
+289.37%
1.06
—
Derivative Product Liabilities
0.21
-67.60%
0.64
+31.56%
0.49
0.00
Financial Assets
0.34
0.00
-100.00%
0.58
-79.36%
2.79
Financial Assets Designatedas Fair Value Through Profitor Loss Total
4.38
+5.82%
4.14
+7.26%
3.86
+393.35%
0.78
Foreign Currency Translation Adjustments
-58.47
-364.82%
-12.58
-14.60%
-10.98
+29.69%
-15.61
Inventories Adjustments Allowances
-20.96
-4.68%
-20.03
-10.38%
-18.14
-12.03%
-16.19
Investmentin Financial Assets
5.64
+0.00%
5.64
+9.51%
5.15
+182.09%
1.83
Investmentsin Associatesat Cost
—
—
—
—
Line Of Credit
30.00
-40.03%
50.03
-40.44%
84.00
+534.24%
13.24
Other Equity Interest
-0.00
—
145.63
+1.95%
142.85
Other Inventories
—
—
—
18.12
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
286.08
+83.65%
155.78
+48.06%
105.21
+1.84%
103.31
Cash Flow From Continuing Operating Activities
286.08
+83.65%
155.78
+48.06%
105.21
+1.84%
103.31
Net Income From Continuing Operations
189.11
+17.98%
160.29
-15.44%
189.55
+1.02%
187.64
Depreciation Amortization Depletion
88.57
+9.81%
80.65
+2.77%
78.48
+21.07%
64.82
Depreciation
74.91
+14.87%
65.22
+4.19%
62.59
+24.23%
50.38
Amortization Cash Flow
13.65
-11.56%
15.44
-2.84%
15.89
+10.02%
14.44
Depreciation And Amortization
88.57
+9.81%
80.65
+2.77%
78.48
+21.07%
64.82
Amortization Of Intangibles
13.65
-11.56%
15.44
-2.84%
15.89
+10.02%
14.44
Other Non Cash Items
20.79
+2189.15%
-0.99
-105.94%
16.76
+139.88%
6.99
Pension And Employee Benefit Expense
-0.45
-453.97%
0.13
+4.13%
0.12
+104.03%
-3.00
Provisionand Write Offof Assets
2.93
-18.26%
3.58
+59.48%
2.25
+133.17%
-6.77
Operating Gains Losses
-0.51
-1233.33%
0.04
+112.64%
-0.36
+88.61%
-3.13
Change In Working Capital
50.63
+390.84%
-17.41
+83.01%
-102.48
+12.96%
-117.74
Change In Receivables
0.89
+123.29%
-3.83
+95.92%
-93.86
-102.19%
-46.42
Changes In Account Receivables
0.89
+123.29%
-3.83
+95.92%
-93.86
-102.19%
-46.42
Change In Inventory
-41.45
-436.87%
12.31
+110.83%
-113.59
-5.80%
-107.37
Change In Payables And Accrued Expense
91.19
+452.25%
-25.89
-124.66%
104.97
+191.17%
36.05
Change In Payable
91.19
+452.25%
-25.89
-124.66%
104.97
+191.17%
36.05
Change In Account Payable
91.19
+452.25%
-25.89
-124.66%
104.97
+191.17%
36.05
Investing Cash Flow
-272.92
+12.02%
-310.21
+26.35%
-421.22
-73.38%
-242.95
Cash Flow From Continuing Investing Activities
-272.92
+12.02%
-310.21
+26.35%
-421.22
-73.38%
-242.95
Net PPE Purchase And Sale
-261.90
+12.54%
-299.45
+30.79%
-432.66
-84.20%
-234.88
Purchase Of PPE
-263.76
+12.84%
-302.60
+30.15%
-433.23
-84.33%
-235.03
Sale Of PPE
1.86
-40.90%
3.15
+445.41%
0.58
+295.21%
0.15
Capital Expenditure
-275.03
+12.29%
-313.57
+29.04%
-441.93
-81.77%
-243.13
Net Investment Purchase And Sale
0.25
-34.81%
0.39
+109.19%
-4.19
-13616.13%
0.03
Sale Of Investment
—
—
—
0.03
Net Business Purchase And Sale
0.00
+100.00%
-0.17
+95.12%
-3.59
0.00
Purchase Of Business
0.00
+100.00%
-0.17
+95.12%
-3.59
0.00
Gain Loss On Sale Of Business
—
—
—
—
Net Intangibles Purchase And Sale
-11.28
-2.78%
-10.97
-26.16%
-8.70
-7.38%
-8.10
Purchase Of Intangibles
-11.28
-2.78%
-10.97
-26.16%
-8.70
-7.38%
-8.10
Net Other Investing Changes
—
—
27.91
—
Financing Cash Flow
22.06
-87.96%
183.22
+15.94%
158.03
+454.84%
-44.54
Cash Flow From Continuing Financing Activities
22.06
-87.96%
183.22
+15.94%
158.03
+454.84%
-44.54
Net Issuance Payments Of Debt
36.80
+31.87%
27.91
-83.83%
172.57
+656.04%
-31.04
Issuance Of Debt
150.00
-21.12%
190.17
-23.17%
247.51
+1774.10%
13.21
Repayment Of Debt
-113.20
+30.24%
-162.27
-116.53%
-74.94
-69.38%
-44.24
Long Term Debt Issuance
150.00
-21.12%
190.17
-23.17%
247.51
+1774.10%
13.21
Long Term Debt Payments
-113.20
+30.24%
-162.27
-116.53%
-74.94
-69.38%
-44.24
Net Long Term Debt Issuance
36.80
+31.87%
27.91
-83.83%
172.57
+656.04%
-31.04
Net Common Stock Issuance
0.00
-100.00%
169.77
0.00
0.00
Common Stock Dividend Paid
-14.74
-1.94%
-14.46
-1.14%
-14.29
-5.88%
-13.50
Cash Dividends Paid
-14.74
-1.94%
-14.46
-1.14%
-14.29
-5.88%
-13.50
Net Other Financing Charges
—
—
-0.25
—
Changes In Cash
35.22
+22.36%
28.78
+118.22%
-157.98
+14.22%
-184.17
Effect Of Exchange Rate Changes
-2.88
-2408.70%
-0.12
+90.04%
-1.16
-161.60%
1.88
Beginning Cash Position
98.27
+41.19%
69.60
-69.57%
228.74
-44.35%
411.04
End Cash Position
130.60
+32.90%
98.27
+41.19%
69.60
-69.57%
228.74
Free Cash Flow
11.04
+107.00%
-157.79
+53.14%
-336.72
-140.83%
-139.81
Common Stock Issuance
0.00
-100.00%
169.77
0.00
0.00
Earnings Losses From Equity Investments
—
—
0.00
0.00
Interest Paid CFO
-6.96
+6.09%
-7.41
-135.12%
-3.15
+9.06%
-3.47
Interest Received CFO
1.44
+12.24%
1.28
+39.15%
0.92
+22.61%
0.75
Issuance Of Capital Stock
0.00
-100.00%
169.77
0.00
0.00
Sale Of Business
—
—
0.00
0.00
Taxes Refund Paid
-59.91
+6.78%
-64.26
+16.29%
-76.77
-197.67%
-25.79
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category